Events

Prime presents at BMO Inaugural Obsesity Summit on March 20

Event will feature David Lassen, chief clinical officer

by Prime Therapeutics
March 15, 2024
Events

BMO will host its first Obesity Summit on March 20, 2024 in New York City. The conference will feature leading biotech and pharmaceutical companies developing medical weight-management therapeutics as well as stakeholders across the continuum of care and delivery.

Event:

The BMO Inaugural Obesity Summit

Date:

March 20, 2024

Educational Sessions:

Payers Panel: Key Considerations for Coverage and Access
Wednesday, March 20 / 1 p.m. ET
Speakers: David Lassen, Chief Clinical Officer (Prime Therapeutics/Magellan Rx); Speaker TBD (Capital Rx); Moderated by Evan Seigerman, Biotechnology & Pharmaceuticals Analyst (BMO Capital Markets)

About Prime Therapeutics

Prime Therapeutics (logo)

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.

Events

Related Articles

Showing 1 to 4 of 135

Related Articles

Showing 1 to 4 of 210

Related Articles

No Results Found

Latest News